These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6695979)

  • 1. The use of hormone implants for climacteric symptoms.
    Cardozo L; Gibb DM; Studd JW; Tuck SM; Thom MH; Cooper DJ
    Am J Obstet Gynecol; 1984 Feb; 148(3):336-7. PubMed ID: 6695979
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study.
    Brincat M; Magos A; Studd JW; Cardozo LD; O'Dowd T; Wardle PJ; Cooper D
    Lancet; 1984 Jan; 1(8367):16-8. PubMed ID: 6140343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of subcutaneous hormone implants during climacteric.
    Cardozo L; Gibb DM; Tuck SM; Thom MH; Studd JW; Cooper DJ
    Maturitas; 1984 Mar; 5(3):177-84. PubMed ID: 6727691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hormone implant therapy--hormonal and clinical effects.
    Barlow DH; Abdalla HI; Roberts AD; Al Azzawi F; Leggate I; Hart DM
    Obstet Gynecol; 1986 Mar; 67(3):321-5. PubMed ID: 3945443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms].
    van Leusden HA
    Ned Tijdschr Geneeskd; 1987 Dec; 131(50):2301-4. PubMed ID: 3696269
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone implants in the climacterium.
    Schleyer-Saunders E
    Z Alternsforsch; 1974; 28(3):205-10. PubMed ID: 4156986
    [No Abstract]   [Full Text] [Related]  

  • 7. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
    Tsvetkov Ts; Tsvetkov K; Petkova U
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric.
    Montgomery JC; Appleby L; Brincat M; Versi E; Tapp A; Fenwick PB; Studd JW
    Lancet; 1987 Feb; 1(8528):297-9. PubMed ID: 2880114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The treatment of climacteric disorders with a combination of estradiol and testosterone--an outline of the pathogenesis of psychic symptoms in the climacterium.
    Navrátil J; Nováková D; Pichner J
    Act Nerv Super (Praha); 1975; 17(4):307-8. PubMed ID: 1221812
    [No Abstract]   [Full Text] [Related]  

  • 10. Oestrogen therapy for the menopause.
    Studd J; Watson N; Henderson A
    Br J Psychiatry; 1990 Dec; 157():931-2. PubMed ID: 2289110
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transdermal estradiol substitution in the postmenopause, individual dosage adjustment and effectiveness in the treatment of climacteric symptoms].
    Schenkel L; von Graffenried A
    Schweiz Rundsch Med Prax; 1987 Mar; 76(14):358-61. PubMed ID: 3589291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone substitution by injectable preparations and skin implants].
    Kuhl H
    Gynakologe; 1986 Dec; 19(4):241-7. PubMed ID: 3817596
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormonal therapy with estradiol and testosterone implants: bone protection?
    Britto R; Araújo L; Barbosa I; Silva L; Rocha S; Valente AP
    Gynecol Endocrinol; 2011 Feb; 27(2):96-100. PubMed ID: 20504104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
    Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
    Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestradiol and testosterone implants after hysterectomy for endometriosis.
    Montgomery JC; Studd JW
    Contrib Gynecol Obstet; 1987; 16():241-6. PubMed ID: 3691097
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone implants.
    Murtagh J; Wraight F
    Aust Fam Physician; 1989 Apr; 18(4):431. PubMed ID: 2525900
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric].
    Lumholtz IB
    Sygeplejersken; 1979 Sep; 79(38):10. PubMed ID: 229580
    [No Abstract]   [Full Text] [Related]  

  • 18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hormone implants on psychological disorders in the climacteric.
    Sherwin BB
    Lancet; 1987 May; 1(8540):1038-9. PubMed ID: 2883380
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.